首页|二甲双胍通过Sirt1抑制神经细胞凋亡减轻蛛网膜下腔出血后的早期脑损伤

二甲双胍通过Sirt1抑制神经细胞凋亡减轻蛛网膜下腔出血后的早期脑损伤

扫码查看
目的 旨在明确二甲双胍(Met)能否通过Sirt1抑制神经元凋亡以减轻蛛网膜下腔出血(SAH)后早期脑损伤(EBI).方法 将小鼠使用简单随机抽样分为假手术组、SAH24h组、SAH+Met 24h组、SAH 48 h组、SAH+Met 48 h组、SAH 72 h组、SAH+Met 72 h组,每组10只.使用视交叉前池注血法建立SAH小鼠模型.各组小鼠进行改良Garcia评分法评分、脑水含量测定、血脑屏障破坏评估及Morris水迷宫实验.检测各组Sirt1、Bcl-2、Bax、Cleaved Caspase-3蛋白水平并结合Tunel实验与Nissl染色分析Met是否抑制EBI过程中神经元凋亡.体外采用胎鼠原代神经元SAH模型,分为对照组、OxyHb组、OxyHb+Met组、OxyHb+Vehicle 组及 OxyHb+Met+EX527 组,每组 12 只,检测各组 Sirt 1、Bcl-2、Bax、Cleaved Caspase-3 蛋白水平并结合 Tunel实验验证动物实验的结果.加入EX527抑制Sirt1研究Met抑制神经元凋亡的可能机制.结果 与SAH各组相比,SAH+Met各组小鼠的神经功能损伤显著改善.与SAH 48 h组相比,SAH+Met 48 h组Sirt1与Bcl-2水平显著升高(P<0.01),Bax和Cleaved Caspase-3水平显著降低(P<0.01),Tunel与Nissl染色结果显示SAH+Met组凋亡的细胞显著减少(P<0.01).在体外实验中,与OxyHb组相比,OxyHb+Met组Sirt1与Bcl-2水平显著升高(P<0.01),Bax和Cleaved Caspase-3水平显著降低(P<0.01),且此作用在加入EX527后受抑制.结论 Met可通过激活Sirt1通路抑制EBI过程的神经元凋亡,改善SAH预后,为SAH的临床治疗提供了新的药物靶点和治疗策略.
Metformin attenuates early brain injury after subarachnoid hemorrhage by inhibiting neuronal apoptosis through Sirt1
Objective To determine whether metformin(Met)can attenuate early brain injury(EBI)after subarachnoid hemorrhage(SAH)by inhibiting neuronal apoptosis through Sirt1.Methods Mice were randomly divided into sham operation group,SAH 24 h group,SAH+Met 24 h group,SAH 48 h group,SAH+Met 48 h group,SAH 72 h group and SAH+Met 72 h group(n=10 per group).The mouse model of SAH was established by blood injection of the anterior cisterna optic chiasma.The modified Garcia score,brain water content,blood-brain barrier damage assessment and Morris water maze test were performed in each group.Sirt1,Bcl-2,Bax,Cleaved Caspase-3 protein levels were detected in each group,and Tunel assay and Nissl staining were combined to determine whether Met inhibited neuronal apoptosis during EBI.Fetal rat prima-ry neuron SAH model was used in vitro and divided into control group,OxyHb group,OxyHb+Met group,OxyHb+Vehicle group and OxyHb+Met+EX527 group(n=12 per group).The protein levels of Sirt1,Bcl-2,Bax,Cleaved Caspase-3 were detected in each group,and the results of animal experiments were verified by Tunel assay.EX527 was added to inhibit Sirt1 to investigate the potential mecha-nism by which Met inhibits neuronal apoptosis.Results Compared with SAH group,neurological dysfunction was significantly improved in the SAH+Met group.Compared with SAH 48h group,Sirt1 and Bcl-2 levels in SAH+Met 48h group were significantly increased(P<0.01),while Bax and Cleaved Caspase-3 levels were significantly decreased(P<0.01).Tunel and Nissl staining showed that the apoptotic cells in SAH+Met group were significantly reduced(P<0.01).In vitro experiments,compared with the OxyHb group,the levels of Sirt1 and Bcl-2 in the OxyHb+Met group were significantly in-creased(P<0.01),and the levels of Bax and Cleaved Caspase-3 were significantly decreased(P<0.01),and this effect was inhibited after the addition of EX527.Conclusion Met can inhibit neuronal apoptosis during the process of EBI by activating the Sirt1 path-way,improve the prognosis of SAH,and provide a new therapeutic target and treatment strategy for clinical treatment of SAH.

subarachnoid hemorrhageearly brain injurymetforminSirt1apoptosis

袁梓轩、张忠华、周晓明、张鑫

展开 >

210002 南京,南京大学医学院附属金陵医院(东部战区总医院)神经外科

蛛网膜下腔出血 早期脑损伤 二甲双胍 Sirt1 凋亡

国家自然科学基金江苏省卫生健康委员会科研项目

82071328K2019017

2024

医学研究生学报
南京军区南京总医院

医学研究生学报

CSTPCD北大核心
影响因子:1.652
ISSN:1008-8199
年,卷(期):2024.37(7)